Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Neuroreport
|
December 21, 2011
Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia
Jack R Rivers, Simran D S Maggo, John C Ashton
Clinical Pharmacokinetics
|
September 16, 2015
Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
Simran D S Maggo, Ruth L Savage, Martin A Kennedy
Clinical Pharmacokinetics
|
February 18, 2016
Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
Simran D S Maggo, Ruth L Savage, Martin A Kennedy
Drug Safety
|
December 15, 2010
Clinical implications of pharmacogenetic variation on the effects of statins
Simran D S Maggo, Martin A Kennedy, David W J Clark
Frontiers in Psychiatry
|
October 17, 2019
The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand
Simran D S Maggo, Kyra L V Sycamore, Allison L Miller, et al.
Frontiers in Pharmacology
|
March 10, 2023
The pharmacogenetics of <i>CYP2D6</i> and <i>CYP2C19</i> in a case series of antidepressant responses
Ping Siu Kee, Simran D S Maggo, Martin A Kennedy, et al.
Frontiers in Genetics
|
November 16, 2020
Pharmacogenetics of Statin-Induced Myotoxicity
Ping Siu Kee, Paul Ken Leong Chin, Martin A Kennedy, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 22, 2023
Long-Range Polymerase Chain Reaction
Ping Siu Kee, Harsheni Karunanathie, Simran D S Maggo, et al.
Frontiers in Genetics
|
June 6, 2022
Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the <i>CYP2C</i> Locus
Ping Siu Kee, Simran D S Maggo, Martin A Kennedy, et al.
Frontiers in Genetics
|
October 31, 2022
Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples
Leonie M Hitchman, Allamanda Faatoese, Tony R Merriman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Neuroreport
|
December 21, 2011
Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia
Jack R Rivers, Simran D S Maggo, John C Ashton
Clinical Pharmacokinetics
|
September 16, 2015
Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
Simran D S Maggo, Ruth L Savage, Martin A Kennedy
Clinical Pharmacokinetics
|
February 18, 2016
Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
Simran D S Maggo, Ruth L Savage, Martin A Kennedy
Drug Safety
|
December 15, 2010
Clinical implications of pharmacogenetic variation on the effects of statins
Simran D S Maggo, Martin A Kennedy, David W J Clark
Frontiers in Psychiatry
|
October 17, 2019
The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand
Simran D S Maggo, Kyra L V Sycamore, Allison L Miller, et al.
Frontiers in Pharmacology
|
March 10, 2023
The pharmacogenetics of <i>CYP2D6</i> and <i>CYP2C19</i> in a case series of antidepressant responses
Ping Siu Kee, Simran D S Maggo, Martin A Kennedy, et al.
Frontiers in Genetics
|
November 16, 2020
Pharmacogenetics of Statin-Induced Myotoxicity
Ping Siu Kee, Paul Ken Leong Chin, Martin A Kennedy, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 22, 2023
Long-Range Polymerase Chain Reaction
Ping Siu Kee, Harsheni Karunanathie, Simran D S Maggo, et al.
Frontiers in Genetics
|
June 6, 2022
Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the <i>CYP2C</i> Locus
Ping Siu Kee, Simran D S Maggo, Martin A Kennedy, et al.
Frontiers in Genetics
|
October 31, 2022
Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples
Leonie M Hitchman, Allamanda Faatoese, Tony R Merriman, et al.
Page
of 2